Morphine remains a foundational agent in the treatment of moderate to severe pain, both acute and chronic, with particular value in oncology, palliative care, and vaso-occlusive crises associated with sickle cell disease. This activity equips healthcare professionals with essential knowledge of morphine’s FDA-approved indications, along with a comprehensive review of its mechanism of action, pharmacokinetics, and key contraindications. It also addresses proper administration techniques, potential drug interactions, and adverse effects, particularly those emphasized in FDA-issued warnings, to support safe and informed clinical decision-making.
Copyright © 2025, StatPearls Publishing LLC.